NJ Bio
-
The Partnership That Makes Advanced Cancer Drug Technology Accessible to Smaller Biotech Companies
The cancer drug technology attracting billions in investment just got a significant manufacturing upgrade Antibody-drug conjugates are one of the most exciting and fastest-growing categories in cancer treatment. The concept is elegant: take a highly targeted antibody that seeks out cancer cells specifically, attach a potent cancer-killing drug to it, and deliver that drug precisely…